Keith A Webster received his Ph.D. in Biochemistry from the University of York in 1981. He is a Professor at the University of Miami (UM), Miller School of Medicine, Director of the UM Vascular Biology Institute, Adjunct Professor of Ophthalmology at Baylor College of Medicine, Walter G. Ross Distinguished Chair of Vascular Biology, CSO of Everglades Biopharma LLC, and Founder and CEO of Integene LLC. His research interests include myocardial and peripheral ischemia, proliferative retinopathy, programmed cell death, gene and stem cell therapy, type 2 diabetes, and mouse models of heart failure.
Keith A Webster received his Ph.D. in Biochemistry from the University of York in 1981. He is a Professor at the University of Miami (UM), Miller School of Medicine, Director of the UM Vascular Biology Institute, Adjunct Professor of Ophthalmology at Baylor College of Medicine, Walter G. Ross Distinguished Chair of Vascular Biology, CSO of Everglades Biopharma LLC, and Founder and CEO of Integene LLC. His research interests include myocardial and peripheral ischemia, proliferative retinopathy, programmed cell death, gene and stem cell therapy, type 2 diabetes, and mouse models of heart failure.